98%
921
2 minutes
20
Background: Rectourethral fistula is a rare disease with a wide variety of etiologies and clinical presentations. A definitive surgical procedure for rectourethral fistula repair has not been established.
Case Presentation: A 13-year-old boy sustained a penetrating injury to the perineum, and developed a symptomatic rectourethral fistula thereafter. Conservative management through urinary diversion and transanal repair was unsuccessful. Fecal diversion with loop colostomy was performed, and three months later, a fistula repair was performed via a transperineal approach with interposition of a local gluteal tissue flap. There were no postoperative complications, and magnetic resonance imaging studies confirmed the successful closure of the fistula. The urinary and fecal diversions were reverted 1 and 6 months after the fistula repair, respectively, and postoperative excretory system complications did not occur.
Conclusions: The transperineal approach with interposition of a local gluteal tissue flap provides a viable surgical option for adolescent patients with rectourethral fistulas who are unresponsive to conservative management.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677871 | PMC |
http://dx.doi.org/10.1186/s40792-021-01335-z | DOI Listing |
J Pediatr Surg
August 2025
Department of Pediatric Surgery, Children Hospital of Guizhou province, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, PR China. Electronic address:
Objective: To explore the efficacy of robotic-assisted anorectoplasty (RAARP) and laparoscopic-assisted anorectoplasty (LAARP) in children with high and intermediate -type anorectal malformations (ARMs).
Methods: This is a post hoc analysis of a multicenter database of high and intermediate -type ARMs patients undergoing RAARP or LAARP at four centers from April 2011 to April 2024. Data on patients' demographics, perioperative outcomes, and postoperative complications were collected.
BMC Womens Health
July 2025
Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
Background: Total pelvic exenteration (PE) is a surgical resection of all pelvic organs used as a palliative treatment for locally advanced or recurrent pelvic malignancies. This case report describes an entero-vascular fistula as a severe complication following radiotherapy in a patient with recurrent cervical cancer who underwent PE.
Case Presentation: We present the case of a 47-year-old woman who was diagnosed with cervical cancer at the age of 43 years, classified as FIGO stage IIB.
Introduction: We present a case of rectourethral fistula complicating urethral trauma, successfully treated using a transanal exposure device.
Case Presentation: A male in his twenties was referred to us with a pelvic fracture urethral injury. Preoperative imaging revealed an urethrorectal fistula.
Int J Impot Res
June 2025
Department of Urology, Hospital Universitario HM Sanchinarro, Instituto Investigación Sanitaria HM Hospitales and ROC Clinic, Madrid, Spain.
Recto-urethral fistulas represent a rare and challenging condition, occurring either congenitally or due to various prostatic and pelvic interventions such as radical prostatectomy and radiation therapies. This condition often manifests with symptoms such as pneumaturia, fecaluria, and urinary tract infections. Despite its rarity, this condition presents significant clinical management challenges due to the lack of consensus on standardized treatment protocols, particularly in patients with a history of irradiation.
View Article and Find Full Text PDFDig Dis Sci
September 2025
Department of Surgery, "Sapienza" University of Rome, Viale Rena Elena 324, Rome, Italy.
Treatment of acquired rectovesical or rectourethral fistula can be very challenging for surgeons. When a conservative approach fails, complex surgery is needed, with a substantial probability of complications and recurrences. In order to minimize the need for major surgery, autologous mesenchymal stem cells have been used to treat fistulas, especially in patients with inflammatory bowel diseases.
View Article and Find Full Text PDF